Canagliflozin vs Pembrolizumab

Canagliflozin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Canagliflozin and Pembrolizumab.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S.

Molecular Weight: Canagliflozin — 444.5170 g/mol.

Type: Canagliflozin — Small molecule; Pembrolizumab — Antibody.